|
PF-29182 |
ESTRADOT 75 ug/dia, parche transdermico |
2007-10-31 |
|
Novartis Pharmaceuticals Corporation |
Estados Unidos de América
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-29804 |
Estalis 50/140 parches transdermicos |
2008-02-17 |
|
Novartis Pharmaceuticals Corporation |
Estados Unidos de América
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-29803 |
Estalis 50/250 parches transdermicos |
2008-02-17 |
|
Novartis Pharmaceuticals Corporation |
Estados Unidos de América
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30190 |
Estalis Sequi 50/140 parches transdermicos |
2008-04-04 |
|
Novartis Pharma Schweiz AG |
Suiza
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30189 |
Estalis Sequi 50/250 parches transdermicos |
2008-04-03 |
|
Novartis Pharma Schweiz AG |
Suiza
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31380 |
ESTRADOT 25 mcg Parches transdermicos |
2008-09-30 |
|
Novartis Pharma AG |
Suiza
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50335 |
NORDITROPIN NORDILET 15 mg/1.5 mL Solución Inyectable |
2019-07-16 |
|
Novo Nordisk A/S |
Dinamarca
|
Amicelco |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51183 |
TRESIBA 100 U/mL Solución inyectable |
2025-03-24 |
|
Novo Nordisk A/S |
Dinamarca
|
Amicelco |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51276 |
TRESIBA 200 U/ml Solución inyectable |
2020-04-24 |
|
Novo Nordisk A/S |
Dinamarca
|
Amicelco |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51320 |
GLUCAGEN 1 mg Polvo liofilizado para solución inyectable |
2020-04-28 |
|
Novo Nordisk A/S |
Dinamarca
|
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|